Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ATAC-seq profiles of glioblastoma stem cells (GSCs), Non-stem tumor cells (NSTCs) and neural progenitor cell (NPC).

ABSTRACT: Both chromatin accessibility and histone modifications are known to influence transcriptional regulation. We investigated the differences of chromatin accessibility among GSCs, NSTCs and NPC using ATAC-seq (assay for transposase-accessible chromatin with high throughput sequencing).

ORGANISM(S): Homo sapiens

PROVIDER: GSE211724 | GEO | 2022/08/28

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

SUV39H1 Maintains Cancer Stem Cells in Glioblastoma [RNA-seq]

Project description:Glioblastoma (GBM) is the deadliest brain cancer, driven in part by GBM stem cells (GSCs) that contribute to therapeutic resistance and tumor recurrence. Effective targeting and elimination of GSCs hold promise for preventing GBM recurrence and achieving potential cures. In this study, we explored the role of the epigenetic regulator SUV39H1 in GSC maintenance and GBM progression. We observed that SUV39H1 is upregulated in GBM samples compared to normal brain tissues. Single-cell RNA-seq data indicated that SUV39H1 is preferentially expressed in GSCs relative to non-stem GBM cells, possibly due to super-enhancer-mediated transcriptional activation. Knockdown of SUV39H1 in patient-derived GSCs impaired their proliferation and stemness. RNA-seq analysis revealed that SUV39H1 regulates G2/M cell cycle progression, stem cell maintenance, and cell death pathways in GSCs. Integrated ATAC-seq (assay for transposase-accessible chromatin followed by sequencing) and RNA-seq analyses demonstrated that targeting SUV39H1 altered chromatin accessibility in key genes associated with these pathways. Treatment with chaetocin, a SUV39H1 inhibitor, mimicked the effects of SUV39H1 knockdown in GSCs and sensitized them to the GBM chemotherapy drug temozolomide (TMZ). In vivo studies using an intracranial patient-derived xenograft model showed that targeting SUV39H1 inhibited GSC-driven tumor formation in mice. Our findings identify SUV39H1 as a critical regulator of GSC maintenance and suggest that targeting SUV39H1 could disrupt GSCs and enhance the efficacy of existing chemotherapy, offering a promising strategy for improving GBM treatment outcomes.

2024-11-06 | GSE273012 | GEO

SUV39H1 Maintains Cancer Stem Cells in Glioblastoma [ATAC-seq]

2024-11-06 | GSE273013 | GEO

Histone modification ChIP-seq profile of Glioblastoma stem cells (GSCs) and Non-stem tumor cells (NSTCs)

Project description:GSCs carry various epigenetic alterations at specific genomic sites functionally implicated in self-maintenance and tumor progression. We used chromatin immunoprecipitation followed by sequencing (ChIP–seq) to investigate the histone modifications of GSCs and NSTCs.

2022-08-28 | GSE211725 | GEO

RNA-seq of Glioblastoma stem cells

Project description:Chromatin accessibility discriminates stem from mature cell populations, enabling the identification of primitive stem-like cells in primary tumors, such as Glioblastoma (GBM) where self-renewing cells driving cancer progression and recurrence are prime targets for therapeutic intervention. We show, using single-cell chromatin accessibility, that primary GBMs harbor a heterogeneous self-renewing population whose diversity is captured in patient-derived glioblastoma stem cells (GSCs). In depth characterization of chromatin accessibility in GSCs identifies three GSC states: Reactive, Constructive, and Invasive, each governed by uniquely essential transcription factors and present within GBMs in varying proportions. Orthotopic xenografts reveal that GSC states associate with survival, and identify an invasive GSC signature predictive of low patient survival. Our chromatin-driven characterization of GSC states improves prognostic precision and identifies dependencies to guide combination therapies.

| EGAS00001003070 | EGA

ATAC-seq profiles of glioblastoma stem cells (GSCs), Non-stem tumor cells (NSTCs) and neural progenitor cell (NPC).

Project description:ATAC-seq profiles of glioblastoma stem cells (GSCs), Non-stem tumor cells (NSTCs) and neural progenitor cell (NPC).

| PRJNA871900 | ENA

NEUROD1 intrinsically initiates differentiation of induced pluripotent stem cells into neural progenitor cells

Project description:We generated ATAC-seq (Assay for Transposase-Accessible Chromatin using sequencing) data and Hi-C data for induced pluripotent stem cell (iPSC), neuronal progentior cell (NPC), and investigated cell type-specific open chromatin regions and related enhancers

2021-01-06 | GSE158382 | GEO

Expression data from glioblastoma stem-like cells (GSCs) and astrocyte co-cultured GSCs

Project description:consequences of astrocytes on GSCs, gene expression profiles generated from glioblastoma stem-like cells grown alone (mono-culture) and compared to those generated 48h after the initiation of co-culture with astrocytes We used microarrays show that astrocytes are capable to modify via a paracrine mechanism GSC gene expression and thus phenotype.

2014-11-07 | GSE63037 | GEO

glioblastoma and glioblastoma stem cells (GSCs), RNA-seq and WGS

Project description:Characterization of glioblastoma tumors and glioblastoma stem cells (GSCs) lines via RNA-seq and/or WGS profiling.

| EGAS00001004395 | EGA

Transcriptional dysregulation impairs efficacy of neural stem cell activation during aging [ATAC-seq]

Project description:To examine whether chromatin accessibility is associated with transcription of age-dependent genes in NSC aging, we profiled the chromatin accessibility at the promoters and enhancers of age-dependent genes using the assay for transposase-accessible chromatin with sequencing (ATAC-seq).

2023-11-02 | GSE214971 | GEO

Human glioblastoma stem cells (GSCs) differentiation: Undifferentiated cells vs. Differentiated cells

Project description:Using four patient-derived GSCs lines and their induced differentiating counterparts, we performed high-throughput microarray analysis to identify the profile changes of lncRNAs and mRNAs. The differentiation status was determined by Immunofluorescence and qRT-PCR.

2019-04-17 | GSE68343 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data